SCHEMBL8473403

SCHEMBL8473403

O=C1CN(c2nccs2)C(=O)N1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
GAA P10253 2/20 0.46
KDM4C Q9H3R0 1/20 0.44
TDP1 Q9NUW8 4/20 0.44
POLB P06746 3/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
APEX1 P27695 1/20 0.44
RECQL P46063 1/20 0.44
HSD17B10 Q99714 3/20 0.41
KDM4E B2RXH2 2/20 0.41
NPC1 O15118 1/20 0.41
HPGD P15428 1/20 0.41
RAB9A P51151 1/20 0.41
ATM Q13315 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MAPT P10636 1/20 0.36
G6PD P11413 1/20 0.36
PKM P14618 1/20 0.36
MPI P34949 1/20 0.36
EP300 Q09472 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3775820 0.73 HSD17B10 (0.51) ALDH1A1GAAKDM4CTDP1POLB
SCHEMBL6411615 0.69 CRBN (0.46) ALDH1A1GAATDP1POLBHSD17B10
SCHEMBL1584075 0.69 ALDH1A1 (0.41) ALDH1A1GAAKDM4CTDP1POLB
SCHEMBL30491903 0.68 PDE3B (0.46) ALDH1A1GAATDP1HSD17B10KDM4E
Hydrochloric Acid SCHEMBL1583648 0.68 ALDH1A1 (0.40) ALDH1A1GAAKDM4CTDP1POLB
SCHEMBL1583412 0.68 KDM4C (0.44) ALDH1A1GAAKDM4CTDP1POLB
SCHEMBL29135322 0.68 TDP1 (0.51) ALDH1A1GAAKDM4CTDP1POLB
SCHEMBL2628993 0.68 L3MBTL1 (0.53) ALDH1A1GAAKDM4CTDP1POLB
Hydrochloric Acid SCHEMBL1583289 0.67 KDM4C (0.43) ALDH1A1GAAKDM4CTDP1POLB
Hydrochloric Acid SCHEMBL1583585 0.67 KDM4C (0.43) ALDH1A1GAAKDM4CTDP1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240299360-A1 ADAMTS INHIBITORS, PREPARATION METHODS AND MEDICINAL USES THEREOF JIANGSU HENGRUI PHARMACEUTICALS CO., LTD (CN) 2024-09-12 US disclosed
US-6004963-A TUMOR NECROSIS FACTOR RELEASE INHIBITORS; IMMUNOMODULATORS GRUENENTHAL GMBH (DE) 1999-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240299360-A1 ADAMTS INHIBITORS, PREPARATION METHODS AND MEDICINAL USES THEREOF ADAMTS5, ADAMTS4, ADAMTS1 ALDH1A1 1671/4885GAA 449/4885KDM4C 2189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.